Robin Taylor
Chief Commercial Officer at Agenus | Lexington, Massachusetts, United States
Robin Taylor’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Chief Commercial Officer at Seattle Genetics in July 2026 - July 2026
Vice-President, Franchise Head, ImmunoOncology at AstraZeneca in July 2026 - July 2026
Vice President, Cancer Immunotherapy Franchise Head at Genentech in July 2026 - July 2026
Vice President, Lung and Cancer Immunotherapy Franchise Head, Global Product Strategy at Genentech in July 2026 - July 2026
Lifecycle Leader, Onartuzumab (MetMAb) at Genentech in July 2026 - July 2026
Senior Director, Oncology Pipeline Head, Global Product Strategy at Genentech in July 2026 - July 2026
Director, BioOncology Pipeline Commercial Development at Genentech in July 2026 - July 2026
Director, Avastin GI Cancers at Genentech in July 2026 - July 2026
Group Product Manager, Avastin at Genentech in July 2026 - July 2026
Senior Product Manager, Avastin at Genentech in July 2026 - July 2026
Product Manager, Herceptin at Genentech in July 2026 - July 2026
Associate Product Manager, Herceptin at Genentech in July 2026 - July 2026
Sales Oncology Specialist, Herceptin at Genentech in July 2026 - July 2026
Owner at Taylor Global Biopharma Consulting in July 2026 - Present
Member, Scientific Advisory Board at Senti Biosciences in July 2026 - Present
Chief Commercial Officer at Agenus in July 2026 - Present
Summer Intern, Rituxan & Herceptin at Genentech in July 1999 - July 1999
Staff Scientist at Mount Sinai Hospital Research Institute, Toronto, Canada in July 1998 - July 1998
Postdoctoral Researcher, Neuroscience at National Institutes of Health in July 1995 - July 1997
Postdoctoral Researcher, Neuroscience at UCSF in July 1993 - July 1995
University of California, Berkeley, Haas School of Business, MBA, January 1998 to January 2000
University of Toronto, Ph.D., January 1985 to January 1993
The University of British Columbia, B.Sc., January 1980 to January 1984
Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell and gene therapies in order to enhance their therapeutic effectiveness against a broad range of diseases that conventional medicines do not readily address. For more information, please visit the Senti Bio website at https://www.sentibio.com.
Discover more about Agenus
Co-Founder and CEO at Senti Biosciences
Co-Founder at Tango Therapeutics
(Mar 2017 – Present)
SVP, Technical Operations at Senti Biosciences
Senior Vice President, Technical Operations at Senti Biosciences
(Jan 2025 – Present)
Vice President at Senti Biosciences
• Head of Discovery Research
• Head of Translational Science
- Led pre-clinical development of SENTI-202, a logic gated CAR NK cell therapy for r/rAML currently in the clinic (PMID: 38669141; corresponding author)
Senior Life Sciences Executive | Public Company Board Member | Audit Committee Chairperson | Expertise in Guiding Companies to Execute Complex Corporate Deals
Board member and Chair of the Audit Committee of Senti Biosciences, Inc. (Nasdaq: SNTI), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform
Technical Development Process Engineer | Innovator || Cell Therapy Specialist | Vendor Management
· Optimizes the upstream cell culture processes for GMP cell therapy manufacturing, improving scalability, operational efficiency, and process consistency while reducing culture vessel utilization by 70%.
· Leads technology transfer initiatives across CMC teams and exter...
Experienced analytical team builder and developer with emphasis on development of control strategies and using data to solve challenges. Cross-discipline thinker focused on collaboration and alignment to enable goals.
Senior Director, Analytical Development at Senti Biosciences
(May 2025 – Present)
What is Robin Taylor email address?
Email Robin Taylor at [email protected] and [email protected]. This email is the most updated Robin Taylor's email found in 2026.
How to contact Robin Taylor?
To contact Robin Taylor send an email to [email protected] or [email protected].
What company does Robin Taylor work for?
Robin Taylor works for Agenus.
What is Robin Taylor's role at Agenus?
Robin Taylor is Chief Commercial Officer
What industry does Robin Taylor work in?
Robin Taylor works in the Biotechnology industry.
